New FTC chief
This article was originally published in The Gray Sheet
Executive Summary
Current Chairman Timothy Muris plans to leave the Federal Trade Commission during the summer, according to a May 11 announcement. Muris has served in the position since June 2001. The Bush Administration has named attorney Deborah Majoras, a partner with Jones Day, to replace Muris at the commission, subject to her confirmation by the Senate. Prior to rejoining Jones Day in early 2004, Majoras worked in the Department of Justice Antitrust Division where she helped DOJ resolve U.S. v. Microsoft...
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.